CoChat

PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.0050172

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Interaction of TRAP1 with Wild-Type and Mutant PINK1 (A) Lysates of HeLa cells expressing C-terminally FLAG-tagged wild-type PINK1 (Input) were affinity purified with anti-FLAG M2 affinity gel, and the eluate fractions were analyzed by immunoblotting with anti-FLAG antibody. (B) Affinity-purified proteins from PINK1-transfected cells and vector control were resolved on SDS-PAGE and detected by Ponceau S staining. Arrows indicate three bands identified by mass spectrometry as TRAP1, PINK1f, and PINK1p. (C) Specificity of the polyclonal anti-PINK1 antibody. Homogenates (50 μg of protein per lane) from rat brain, liver, untransfected PC12 cells, and transfected PC12 cells expressing wild-type (WT) or mutant PINK1 were analyzed by immunoblotting with anti-PINK1 and anti-actin antibodies. (D) Endogenous PINK1 interacts with TRAP1. PC12 cell lysates (Input) were immunoprecipitated with anti-TRAP1 antibody, followed by immunoblotting with anti-PINK1 and anti-TRAP1 antibodies. IgG HC, IgG heavy chain. (E) Lysates from PC12 cells transfected with FLAG-tagged wild-type or mutant PINK1 were immunoprecipitated with anti-FLAG antibody, followed by immunoblotting using anti-TRAP1 and anti-FLAG antibodies.
Figure 1 Interaction of TRAP1 with Wild-Type and Mutant PINK1 (A) Lysates of HeLa cells expressing C-terminally FLAG-tagged wild-type PINK1 (Input) were affinity purified with anti-FLAG M2 affinity gel, and the eluate fractions were analyzed by immunoblotting with anti-FLAG antibody. (B) Affinity-purified proteins from PINK1-transfected cells and vector control were resolved on SDS-PAGE and detected by Ponceau S staining. Arrows indicate three bands identified by mass spectrometry as TRAP1, PINK1f, and PINK1p. (C) Specificity of the polyclonal anti-PINK1 antibody. Homogenates (50 μg of protein per lane) from rat brain, liver, untransfected PC12 cells, and transfected PC12 cells expressing wild-type (WT) or mutant PINK1 were analyzed by immunoblotting with anti-PINK1 and anti-actin antibodies. (D) Endogenous PINK1 interacts with TRAP1. PC12 cell lysates (Input) were immunoprecipitated with anti-TRAP1 antibody, followed by immunoblotting with anti-PINK1 and anti-TRAP1 antibodies. IgG HC, IgG heavy chain. (E) Lysates from PC12 cells transfected with FLAG-tagged wild-type or mutant PINK1 were immunoprecipitated with anti-FLAG antibody, followed by immunoblotting using anti-TRAP1 and anti-FLAG antibodies.CC BY · PubMed Central
Figure 2 PINK1 and TRAP1 Colocalize in the Mitochondrial Inner Membrane and the Intermembrane Space (A) Post-nuclear supernatants of PC12 cells were fractionated on a 5%–15% linear Optiprep gradient, and the fractions were analyzed by immunoblotting for PINK1, TRAP1, TIMM23, and CANX. (B) Mitochondria (Mito) isolated from PC12 cells were fractionated into matrix, inner mitochondrial membrane (IM), intermembrane space (IMS), and outer mitochondrial membrane (OM) fractions, and analyzed by immunoblotting for PINK1, TRAP1, and markers of mitochondrial subcompartments: HSPD1 (matrix), TIMM23 (IM), cytochrome c (IMS), and VDAC (OM).
Figure 2 PINK1 and TRAP1 Colocalize in the Mitochondrial Inner Membrane and the Intermembrane Space (A) Post-nuclear supernatants of PC12 cells were fractionated on a 5%–15% linear Optiprep gradient, and the fractions were analyzed by immunoblotting for PINK1, TRAP1, TIMM23, and CANX. (B) Mitochondria (Mito) isolated from PC12 cells were fractionated into matrix, inner mitochondrial membrane (IM), intermembrane space (IMS), and outer mitochondrial membrane (OM) fractions, and analyzed by immunoblotting for PINK1, TRAP1, and markers of mitochondrial subcompartments: HSPD1 (matrix), TIMM23 (IM), cytochrome c (IMS), and VDAC (OM).CC BY · PubMed Central
Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.
Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.CC BY · PubMed Central
Figure 4 Wild-Type PINK1, but Not Kinase-Dead or PD-Linked Mutant PINK1, Protects against Oxidative-Stress-Induced Apoptosis (A) PC12 cells expressing wild-type (WT) or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 for 16 h. The extent of cell survival was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. aSignificantly different from the vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). (B) Immunoblot analysis of cytochrome c (Cyt. c) in the cytosol and mitochondria fractions isolated from PC12 cells expressing wild-type or mutant PINK1 after treatment with 400 μM H2O2 for the indicated times. (C) The level of cytochrome c released to the cytosol is normalized to the total level of cytochrome c in each cell sample. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01).
Figure 4 Wild-Type PINK1, but Not Kinase-Dead or PD-Linked Mutant PINK1, Protects against Oxidative-Stress-Induced Apoptosis (A) PC12 cells expressing wild-type (WT) or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 for 16 h. The extent of cell survival was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. aSignificantly different from the vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). (B) Immunoblot analysis of cytochrome c (Cyt. c) in the cytosol and mitochondria fractions isolated from PC12 cells expressing wild-type or mutant PINK1 after treatment with 400 μM H2O2 for the indicated times. (C) The level of cytochrome c released to the cytosol is normalized to the total level of cytochrome c in each cell sample. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01).CC BY · PubMed Central
Figure 5 PINK1 Knockdown Reduces TRAP1 Phosphorylation and Protection against Oxidative Stress (A) PC12 cells were transfected with vehicle (control), NT siRNA, or PINK1-specific siRNAs (PINK1 siRNA-1 and PINK1 siRNA-2). The levels of PINK1 and actin in the cell lysates were analyzed by immunoblotting with anti-PINK1 and anti-actin antibodies. (B) PC12 cells transfected with the indicated siRNA or vehicle (control) were treated with 400 μM H2O2 for the indicated times. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine and anti-TRAP1 antibodies. (C) Normalized levels of in vivo TRAP1 phosphorylation in the control and siRNA-transfected cells. Data represent mean ± SEM from three independent experiments. *Significantly different from the corresponding H2O2-treated control cells (p < 0.01). AU, arbitrary units. (D) PC12 cells transfected with vehicle (control) or the indicated siRNAs were treated with 400 μM H2O2 for 16 h. Cell viability was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.01). (E) PC12 cells co-transfected with an expression vector encoding enhanced green fluorescent protein (pEGFP) and vehicle (control) or indicated siRNAs were treated with 400 μM H2O2 for 16 h. Transfected cells were shown by the green fluorescence emitted by green fluorescent protein (GFP), and nuclear morphology was visualized by DAPI staining (blue). Arrowheads indicate transfected cells with apoptotic nuclei. Scale bar, 10 μm. (F) Apoptosis is expressed as the percentage of transfected cells with apoptotic nuclear morphology. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.01).
Figure 5 PINK1 Knockdown Reduces TRAP1 Phosphorylation and Protection against Oxidative Stress (A) PC12 cells were transfected with vehicle (control), NT siRNA, or PINK1-specific siRNAs (PINK1 siRNA-1 and PINK1 siRNA-2). The levels of PINK1 and actin in the cell lysates were analyzed by immunoblotting with anti-PINK1 and anti-actin antibodies. (B) PC12 cells transfected with the indicated siRNA or vehicle (control) were treated with 400 μM H2O2 for the indicated times. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine and anti-TRAP1 antibodies. (C) Normalized levels of in vivo TRAP1 phosphorylation in the control and siRNA-transfected cells. Data represent mean ± SEM from three independent experiments. *Significantly different from the corresponding H2O2-treated control cells (p < 0.01). AU, arbitrary units. (D) PC12 cells transfected with vehicle (control) or the indicated siRNAs were treated with 400 μM H2O2 for 16 h. Cell viability was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.01). (E) PC12 cells co-transfected with an expression vector encoding enhanced green fluorescent protein (pEGFP) and vehicle (control) or indicated siRNAs were treated with 400 μM H2O2 for 16 h. Transfected cells were shown by the green fluorescence emitted by green fluorescent protein (GFP), and nuclear morphology was visualized by DAPI staining (blue). Arrowheads indicate transfected cells with apoptotic nuclei. Scale bar, 10 μm. (F) Apoptosis is expressed as the percentage of transfected cells with apoptotic nuclear morphology. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.01).CC BY · PubMed Central
Figure 6 PINK1 Depletion Increases Cytochrome c Release from Mitochondria (A) PC12 cells transfected with the indicated siRNA or vehicle (control) were treated with 400 μM H2O2 for the indicated times. The levels of cytochrome c (Cyt. c) and actin in the cytosol were determined by immunoblotting with anti-cytochrome c and anti-actin antibodies. (B) The level of cytochrome c released to the cytosol is normalized to the level of actin in each cell sample. Data represent mean ± SEM from three independent experiments. *Significantly different from the corresponding H2O2-treated control cells (p < 0.01). AU, arbitrary units. (C) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs were treated with 400 μM H2O2 for 16 h. Cell morphology was imaged by using phase-contrast microscopy (grey), transfected cells were visualized by the green fluorescence emitted by green fluorescent protein (GFP), and the cellular distribution of cytochrome c was detected by immunostaining with anti-cytochrome c antibody (red). Transfected cells with mitochondrial cytochrome c staining are indicated by arrows, and those with diffuse, cytosolic cytochrome c staining are indicated by arrowheads. Scale bar, 10 μm. (D) Quantification of the percentage of transfected cells showing cytochrome c release. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.05).
Figure 6 PINK1 Depletion Increases Cytochrome c Release from Mitochondria (A) PC12 cells transfected with the indicated siRNA or vehicle (control) were treated with 400 μM H2O2 for the indicated times. The levels of cytochrome c (Cyt. c) and actin in the cytosol were determined by immunoblotting with anti-cytochrome c and anti-actin antibodies. (B) The level of cytochrome c released to the cytosol is normalized to the level of actin in each cell sample. Data represent mean ± SEM from three independent experiments. *Significantly different from the corresponding H2O2-treated control cells (p < 0.01). AU, arbitrary units. (C) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs were treated with 400 μM H2O2 for 16 h. Cell morphology was imaged by using phase-contrast microscopy (grey), transfected cells were visualized by the green fluorescence emitted by green fluorescent protein (GFP), and the cellular distribution of cytochrome c was detected by immunostaining with anti-cytochrome c antibody (red). Transfected cells with mitochondrial cytochrome c staining are indicated by arrows, and those with diffuse, cytosolic cytochrome c staining are indicated by arrowheads. Scale bar, 10 μm. (D) Quantification of the percentage of transfected cells showing cytochrome c release. Data represent mean ± SEM from three independent experiments. *Significantly different from the H2O2-treated control cells (p < 0.05).CC BY · PubMed Central
Figure 7 TRAP1 Depletion Abolishes the Effects of Wild-Type and Mutant PINK1 on Cell Vulnerability to Oxidative Stress (A) PC12 cells were transfected with vehicle (control), NT siRNA, or TRAP1-specific siRNAs (TRAP1 siRNA-1 and TRAP1 siRNA-2). The levels of TRAP1 and actin in the cell lysates were analyzed by immunoblotting with anti-TRAP1 and anti-actin antibodies. (B) PC12 cells treated with TRAP1 siRNA-2 or NT siRNA were either untransfected (UT) or transfected with wild-type (WT) or mutant PINK1 as indicated. Vehicle-treated, non-transfected PC12 cells were used as the control. Cells were exposed to 400 μM H2O2 for 16 h, and the extent of cell survival was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant. (C) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs and PINK1 plasmids were treated with 400 μM H2O2 for 16 h, and the extent of apoptosis was determined by morphological analysis of DAPI-stained nuclei. The percentage of transfected cells with apoptotic nuclear morphology was quantified. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant. (D) The levels of cytochrome c (Cyt. c) and actin in the cytosol fractions from cells described in (B) were determined by immunoblotting with anti-cytochrome c and anti-actin antibodies. (E) The level of cytochrome c released to the cytosol is normalized to the level of actin in each cell sample. Data represent mean ± SEM from three independent experiments. *, p < 0.01; ns, not significant. AU, arbitrary units. (F) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs and PINK1 plasmids were treated with 400 μM H2O2 for 16 h, and the cellular distribution of cytochrome c was detected by immunostaining with anti-cytochrome c antibody. The percentage of transfected cells showing cytochrome c release was quantified. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant.
Figure 7 TRAP1 Depletion Abolishes the Effects of Wild-Type and Mutant PINK1 on Cell Vulnerability to Oxidative Stress (A) PC12 cells were transfected with vehicle (control), NT siRNA, or TRAP1-specific siRNAs (TRAP1 siRNA-1 and TRAP1 siRNA-2). The levels of TRAP1 and actin in the cell lysates were analyzed by immunoblotting with anti-TRAP1 and anti-actin antibodies. (B) PC12 cells treated with TRAP1 siRNA-2 or NT siRNA were either untransfected (UT) or transfected with wild-type (WT) or mutant PINK1 as indicated. Vehicle-treated, non-transfected PC12 cells were used as the control. Cells were exposed to 400 μM H2O2 for 16 h, and the extent of cell survival was assessed by using the MTT assay. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant. (C) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs and PINK1 plasmids were treated with 400 μM H2O2 for 16 h, and the extent of apoptosis was determined by morphological analysis of DAPI-stained nuclei. The percentage of transfected cells with apoptotic nuclear morphology was quantified. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant. (D) The levels of cytochrome c (Cyt. c) and actin in the cytosol fractions from cells described in (B) were determined by immunoblotting with anti-cytochrome c and anti-actin antibodies. (E) The level of cytochrome c released to the cytosol is normalized to the level of actin in each cell sample. Data represent mean ± SEM from three independent experiments. *, p < 0.01; ns, not significant. AU, arbitrary units. (F) PC12 cells co-transfected with pEGFP and vehicle (control) or indicated siRNAs and PINK1 plasmids were treated with 400 μM H2O2 for 16 h, and the cellular distribution of cytochrome c was detected by immunostaining with anti-cytochrome c antibody. The percentage of transfected cells showing cytochrome c release was quantified. Data represent mean ± SEM from three independent experiments. *, p < 0.05; ns, not significant.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 41

  1. Lang, 1998, N Engl J Med, 339, 1044
  2. Farrer, 2006, Nat Rev Genet, 7, 306
  3. Schapira, 1989, Lancet, 1, 1269
  4. Betarbet, 2002, Bioessays, 24, 308
  5. Valente, 2004, Science, 304, 1158
  6. Hatano, 2004, Ann Neurol, 56, 424
  7. Bonifati, 2005, Neurology, 65, 87
  8. Zadikoff, 2006, Mov Disord, 21, 875
  9. Hedrich, 2006, Arch Neurol, 63, 833
  10. Criscuolo, 2006, Mov Disord, 21, 1265
  11. Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
  12. Silvestri, 2005, Hum Mol Genet, 14, 3477
  13. Gandhi, 2006, Brain, 129, 1720
  14. Nakajima, 2003, Cancer Lett, 201, 195
  15. Petit, 2005, J Biol Chem, 280, 34025
  16. Deng, 2005, Biochem Biophys Res Commun, 337, 1133
  17. Clark, 2006, Nature, 441, 1162
  18. Park, 2006, Nature, 441, 1157
  19. Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
  20. Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
  21. Song, 1995, J Biol Chem, 270, 3574
  22. Chen, 1996, Mol Cell Biol, 16, 4691
  23. Felts, 2000, J Biol Chem, 275, 3305
  24. Beere, 2005, J Clin Invest, 115, 2633
  25. Muchowski, 2005, Nat Rev Neurosci, 6, 11
  26. Masuda, 2004, J Biol Chem, 279, 42503
  27. Sim, 2006, Hum Mol Genet, 15, 3251
  28. Olzmann, 2004, J Biol Chem, 279, 8506
  29. Chin, 2000, J Biol Chem, 275, 1191
  30. Choi, 2004, J Biol Chem, 279, 13256
  31. Choi, 2006, J Biol Chem, 281, 10816
  32. Chin, 2001, J Biol Chem, 276, 7069
  33. Ninomiya-Tsuji, 1999, Nature, 398, 252
  34. Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
  35. Li, 2002, J Biol Chem, 277, 28212
  36. Hovius, 1990, Biochim Biophys Acta, 1021, 217
  37. Kirk, 2006, J Cell Sci, 119, 4689
  38. Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
  39. Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
  40. Yang, 1997, Science, 275, 1129
  41. Sherer, 2002, J Neurosci, 22, 7006

Cited by

See all 596

Metadata

Authors
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
Affiliations
Emory University (US)
Corresponding author
  • Chin, Lih-Shen
  • Li, Lian
Venue
PLoS Biology
Published
2007-06-19
Volume
5
Issue
7
Pages
e172
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W2055538245
Cited by
596
References
44
Citations by year
2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
FWCI
42.37
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute on Aging (AG021489, R01AG021489)
  • National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
MeSH terms
PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. https://app.cochat.ai/papers/10.1371/journal.pbio.0050172
The paper
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007). PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biology. https://doi.org/10.1371/journal.pbio.0050172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.